SpikImm has been founded by Truffle Capital and Institut Pasteur. SpikImm’s unique mission is to develop prophylactic mAbs against severe viral diseases in immunocompromised patients. First product is a potent anti-BK virus mAb to protect kidney transplant patients from severe complications caused by BKV, including nephropathies that may result in graft loss.
Company Details
- Employees
- 6
- Address
- 53, Rue De Turbigo, Paris,île-De-France 75003,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://spikimm.com/
- HQ
- Paris, Île-de-France
Spikimm Questions
Spikimm's website is https://spikimm.com/
Spikimm's LinkedIn profile is https://fr.linkedin.com/company/spikimm
Spikimm has
6 employees.
View email and phone details for 6
employees at Spikimm.
Spikimm's industry is
Biotechnology Research
Spikimm's top competitors are
Holistick Medical,
Diamidex,
Brainvectis,
Pk Med,
Adipophyt,
Ipcure,
Mitologics,
Bariatek,
Caranx Medical,
Skinosive.
Spikimm's categories are Biotechnology Research
